Publications 2024

Buer S, Hagen BI, Søraas A, White RA, Bø R, Ellingjord-Dale M, Istre MS, Brunvoll SH, Lerdal A, Landrø NI, Nygaard AB, Stubberud J (2024)
Executive deficits after SARS-CoV-2 infection: A cross-sectional population study
Brain Behav Immun Health, 41, 100857
DOI 10.1016/j.bbih.2024.100857, PubMed 39314761

Ellingjord-Dale M, Nygaard AB, Støer NC, Bø R, Landrø NI, Brunvoll SH, Istre M, Kalleberg KT, Dahl JA, Geng L, Tsilidis K, Riboli E, Ursin G, Søraas A (2024)
Temporal trajectories of long-COVID symptoms in adults with 22 months follow-up in a prospective cohort study in Norway
Int J Infect Dis, 149, 107263 (in press)
DOI 10.1016/j.ijid.2024.107263, PubMed 39419167

Menkir TF, Citarella BW, Sigfrid L, Doshi Y, Reyes LF, Calvache JA, Kildal AB, Nygaard AB, Holter JC, Panda PK, Jassat W, Merson L, Donnelly CA, Santillana M, Buckee C, Verguet S, Hejazi NS, ISARIC Clinical Characterisation Group (2024)
Modeling the relative influence of socio-demographic variables on post-acute COVID-19 quality of life
medRxiv
DOI 10.1101/2024.02.21.24303099, PubMed 39040190

Søraas A, Brunvoll SH, Nygaard AB, Dahl JA, Ursin G (2024)
Post-COVID-19 condition symptoms 6-12 months after hospitalisation in Wuhan
Lancet, 403 (10434), 1336
DOI 10.1016/S0140-6736(24)00414-8, PubMed 38582558

Publications 2022

Brunvoll SH, Nygaard AB, Ellingjord-Dale M, Holland P, Istre MS, Kalleberg KT, Søraas CL, Holven KB, Ulven SM, Hjartåker A, Haider T, Lund-Johansen F, Dahl JA, Meyer HE, Søraas A (2022)
Prevention of covid-19 and other acute respiratory infections with cod liver oil supplementation, a low dose vitamin D supplement: quadruple blinded, randomised placebo controlled trial
BMJ, 378, e071245
DOI 10.1136/bmj-2022-071245, PubMed 36215222

Brunvoll SH, Nygaard AB, Fagerland MW, Holland P, Ellingjord-Dale M, Dahl JA, Søraas A (2022)
Post-acute symptoms 3-15 months after COVID-19 among unvaccinated and vaccinated individuals with a breakthrough infection
Int J Infect Dis, 126, 10-13
DOI 10.1016/j.ijid.2022.11.009, PubMed 36375693

Ellingjord-Dale M, Kalleberg KT, Istre MS, Nygaard AB, Brunvoll SH, Eggesbø LM, Dahl JA, Kjetland EF, Ursin G, Søraas A (2022)
The use of public transport and contraction of SARS-CoV-2 in a large prospective cohort in Norway
BMC Infect Dis, 22 (1), 252
DOI 10.1186/s12879-022-07233-5, PubMed 35287611

Søraas A, Grødeland G, Granerud BK, Ueland T, Lind A, Fevang B, Murphy SL, Huse C, Nygaard AB, Steffensen AK, Al-Baldawi H, Holberg-Petersen M, Andresen LL, Ågnes C, Ranheim T, Schanke Y, Istre M, Dahl JA, Chopra A, Dudman S, Kaarbø M, Andersen JT, Vaage EB, Tran TT, Vaage JT et al. (2022)
Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity
Front Immunol, 13, 964525
DOI 10.3389/fimmu.2022.964525, PubMed 36159859

Publications 2020

Nygaard AB, Tunsjø HS, Meisal R, Charnock C (2020)
A preliminary study on the potential of Nanopore MinION and Illumina MiSeq 16S rRNA gene sequencing to characterize building-dust microbiomes
Sci Rep, 10 (1), 3209
DOI 10.1038/s41598-020-59771-0, PubMed 32081924

Ullmann IF, Nygaard AB, Tunsjø HS, Charnock C (2020)
Whole genome sequencing and antibiotic diffusion assays, provide new insight on drug resistance in the genus Pedobacter
FEMS Microbiol Ecol, 96 (6)
DOI 10.1093/femsec/fiaa088, PubMed 32386210

Publications 2018

Nygaard AB, Charnock C (2018)
Longitudinal development of the dust microbiome in a newly opened Norwegian kindergarten
Microbiome, 6 (1), 159
DOI 10.1186/s40168-018-0553-x, PubMed 30219104

Nygaard AB, Charnock C (2018)
The bacterial composition of ventilation filter dust in Norwegian pre-school nurseries
Indoor Built Environ., 27 (10), 1392-1404
DOI 10.1177/1420326X17713831